The Orchestra Study: An 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease

  • STATUS
    Not Recruiting
  • sponsor
    UCB Biopharma SRL
Updated on 29 January 2023
Investigator
UCB BioSciences, Inc.
Primary Contact
HealthPartners Neuroscience Ct (9.0 mi away) Contact
+41 other location

Summary

The Orchestra Study will examine an investigational medication called UCB0599 in patients with early-stage Parkinson’s disease .
 
It will include patients with Parkinson’s disease (newly diagnosed or early-stage disease) from several countries across North America and Europe. As it is assessing disease and symptom progression over a long period of time, the Orchestra Study can only recruit patients with early-stage Parkinson’s disease (diagnosed within the last 2 years) who show mild symptoms.
 
The study could last up to 21 months for every participant. Participants will be randomly assigned (like drawing straws) to receive either the study drug or placebo; they will have an equal chance (50%) of receiving either the study drug or a placebo (a placebo looks like the study drug but contains no medicinally active ingredients). The study drug or placebo is given orally (by mouth) twice a day every day for 18 months.
 
Participation in the Orchestra Study will include visits at the study site with the study doctor and study team, as well as optional home visits. Home visits enable the study team to continue monitoring the participant's health and well-being while limiting the number of trips to the study site. A research nurse will visit the participant's home to carry out the required tests and procedures while the participant speaks to the study doctor and his or her team over video.
 
For more information about the study, you can visit the study website at https://orchestra-study.com.
 
If you want to find out if you may qualify to participate in the study, please visit the study pre-screener webpage: https://orchestra.researchstudytrial.com.
 
The study is also listed on the clinicaltrials.gov database for clinical trials: https://clinicaltrials.gov/ct2/show/NCT04658186

Description


Details
Condition Early-stage Parkinson's Disease
Clinical Study IdentifierTX292034
SponsorUCB Biopharma SRL
Last Modified on29 January 2023

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note